Single domain antibodies as therapeutics for solid tumor treatment
2024-08-13
BackgroundTraditional cancer treatments, including surgery, chemotherapy, and radiotherapy, are often poorly targeted and, while killing tumor cells, can damage normal cells, resul...
Lipid control protein PCSK9
2024-08-12
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted serine protease primarily synthesized in the liver. It primarily binds to the low-density lipoprotein receptor (...
Human epidermal growth factor receptor HER3
2024-08-09
HER3 is a human epidermal growth factor receptor (ERBB3). HER3 protein belongs to the ErbB/HER receptor tyrosine kinase (RTK) family and is expressed in many types of tumors. HER3 ...
rhIL-7-hyFc improves the efficacy of CAR-T cells in the treatment of solid tumors
2024-08-08
BackgroundGenetically engineered T cells expressing chimeric antigen receptors (CARs) are an emerging cancer immunotherapy. So far, the US Food and Drug Administration (FDA) has ap...
Thymic stromal lymphopoietin TSLP
2024-08-08
Thymic stromal lymphopoietin (TSLP) is a pleiotropic cytokine that acts on multiple cell lineages, including dendritic cells, T cells, B cells, neutrophils, mast cells, eosinophils...
ANV419 has a strong ability to stimulate CD8-T cells and natural killer cells
2024-08-07
BackgroundInterleukin-2 (IL-2) is an agonist that plays a crucial role in cancer immunotherapy. High-dose recombinant IL-2 (Proleukin®/aldesleukin) is the first approved cytokine-b...
Strategies to overcome the challenges of low or no expression of heterologous proteins in Escherichia coli
2024-08-07
BackgroundProtein expression is a critical process in a wide range of biological systems. Escherichia coli, a microbial host widely used in industrial catalysis and healthcare, oft...